Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients.

Clin Mol Hepatol · 2017 · PMC5381841 · PMID 28190329

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

In the HBeAg-negative group, the CVS was lower in the adefovir-experience group, although it failed to reach statistical significance ( Table 5 ).

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.